Prescription drug · NDA
Furoscix (Furosemide injection 80 mg/ 10 ml) NDC 71767-100
Furosemide 8 mg/mL · Injection · Subcutaneous · scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71767-100-01 | 7176701000171767010001 | 1 CARTON in 1 KIT (71767-100-01) / 1 CARTRIDGE in 1 CARTON / 10 mL in 1 CARTRIDGEMarketed from Nov 14, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Furoscix
- Generic name (nonproprietary)
- furosemide injection 80 mg/ 10 ml
- Active ingredients
- Furosemide — 8 mg/mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Labeler
- scPharmaceuticals Inc., a wholly owned subsidiary of MannKind CorporationNDC labeler code 71767
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 209988
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis at Loop of Henle (Physiologic effect)
- Identifiers
- Product ID 71767-100_57ef4d44-0cc5-db23-e063-6294a90a50ccSPL ID 57ef4d44-0cc5-db23-e063-6294a90a50ccSPL set ID eac958dd-8d43-e44e-e053-2995a90a4d5eRxCUI 2621022, 2621028, 2747765, 2747769UNII 7LXU5N7ZO5UPC 0371767100013
- Pharmacologic class
- Loop Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471767010001followed by a unit qualifier and the quantityPackage 71767-0100-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
FUROSCIX is indicated for the treatment of edema in pediatric patients weighing 43 kg and above and in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome. FUROSCIX is a loop diuretic indicated for the treatment of edema in pediatric patients weighing 43 kg and above and in adult patients with chronic heart failure or chronic kidney disease, including the nephrotic syndrome. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 71767-100
- What is NDC 71767-100?
- 71767-100 is the product NDC for Furoscix (furosemide injection 80 mg/ 10 ml), Furosemide 8 mg/mL injection, listed with the FDA by scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Furoscix (Furosemide injection 80 mg/ 10 mL).
- What is the active ingredient?
- Furosemide.
- Who is the labeler?
- scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation, NDC labeler code 71767. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Furoscix?
- 1 other product NDC are listed under this name. See all Furoscix NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Furoscix products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Furoscixfurosemide | Furosemide 80 mg/mL | InjectionSubcutaneous | scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation | 71767-111 | 71767-0111-01 |
Other NDCs under NDA 209988
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Furoscixfurosemide | Furosemide 80 mg/mL | InjectionSubcutaneous | scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation | 71767-111 |